focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBH Macro GBP Regulatory News (BHMG)

Share Price Information for BH Macro GBP (BHMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 352.50
Bid: 352.50
Ask: 353.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.284%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 352.50
BHMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Supplementary Prospectus

4 Oct 2023 11:57

BH Macro Limited - Publication of a Supplementary Prospectus

BH Macro Limited - Publication of a Supplementary Prospectus

PR Newswire

LONDON, United Kingdom, October 04

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR TO ANY US PERSON, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY OTHER JURISDICTION IN WHICH ITS DISTRIBUTION MAY BE UNLAWFUL

4 October 2023

BH MACRO LIMITED (the “Company”)

Publication of Supplementary Prospectus

(an authorised closed-ended collective investment scheme established as a non-cellular company limited by shares under the laws of Guernsey with registration number 46235)

LEI: 549300ZOFF0Z2CM87C29

The Company’s board of directors (the “Board”) announces that it has today published a supplementary prospectus (the “Supplementary Prospectus”) supplementing the prospectus published by the Company on 23 January 2023 in relation to the Initial Issue and Issuance Programme of, in aggregate, up to 220 million new ordinary shares of no par value each in the capital of the Company (“Shares”) to be denominated as either Sterling shares (the “Sterling Shares”) or US dollar shares (the “US Dollar Shares”) (the “Prospectus”).

The Supplementary Prospectus has been issued following the publication of the Company’s interim report and unaudited financial statements of the Company as at and for the six month period to 30 June 2023 (the “2023 Interim Report”) and the publication of the unaudited consolidated financial statements of the Master Fund as at and for the period ending 30 June 2023 of Brevan Howard Master Fund Limited (the “2023 Master Fund Interim Financial Statements”).

The Prospectus (comprising a summary, a registration document and a securities note) published by the Company on 23 January 2023, together with the Supplementary Prospectus and the supplementary prospectus published by the Company on 18 April 2023, comprise the Prospectus in relation to the Issuance Programme for up to 220 million new Shares, of which 146,875,600 Shares (to be denominated either as Sterling Shares or US Dollar Shares) remain available for issue.

Copies of the Supplementary Prospectus and the 2023 Interim Report will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. Copies of the Supplementary Prospectus, the 2023 Interim Report and the 2023 Master Fund Interim Financial Statements are available on the Company's website at www.bhmacro.com

Enquiries

BH MacroRichard HorlickChairman

J.P. Morgan CazenoveWilliam Simmonds / Rupert Budge  Tel: +44 (0) 20 7742 4000

Important Notice

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed by any person for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

Nothing contained herein constitutes or should be construed as (i) investment, tax, financial, accounting or legal advice (ii) a representation that any investment or strategy is suitable or appropriate to individual circumstances or (iii) a personal recommendation.

J.P. Morgan Securities plc, which conducts its UK investment banking activities as J.P. Morgan Cazenove ("JPMC"), which is authorised by the Prudential Regulation Authority and regulated by the Prudential Regulation Authority and the FCA in the United Kingdom, is acting exclusively for the Company and no-one else in connection with the Initial Issue and will not be responsible to anyone other than the Company for providing the protections afforded to customers of JPMC or for providing advice in relation to the Initial Issue, or any other matter referred to herein.



Date   Source Headline
3rd Apr 20245:27 pmPRNTransaction in Own Shares
3rd Apr 202410:59 amPRNConversion of Securities
2nd Apr 20245:05 pmPRNTransaction in Own Shares
2nd Apr 202410:55 amPRNTotal Voting Rights
28th Mar 20245:00 pmPRNTransaction in Own Shares
28th Mar 202412:27 pmPRNBlock Listing Six Monthly Return
28th Mar 20247:00 amPRNAnnual Report and Audited Financial Statements 2023
27th Mar 20245:11 pmPRNTransaction in Own Shares
26th Mar 20245:40 pmPRNNet Asset Value(s)
26th Mar 20245:31 pmPRNTransaction in Own Shares
25th Mar 20245:15 pmPRNNet Asset Value(s)
25th Mar 20245:11 pmPRNTransaction in Own Shares
22nd Mar 20245:20 pmPRNTransaction in Own Shares
21st Mar 20245:16 pmPRNTransaction in Own Shares
21st Mar 202412:26 pmPRNTransparency Reporting
20th Mar 20245:14 pmPRNMonthly Shareholder Report - February 2024
20th Mar 20245:07 pmPRNTransaction in Own Shares
19th Mar 20245:36 pmPRNNet Asset Value(s)
19th Mar 20245:17 pmPRNTransaction in Own Shares
18th Mar 20245:10 pmPRNTransaction in Own Shares
15th Mar 20245:09 pmPRNTransaction in Own Shares
14th Mar 20245:11 pmPRNTransaction in Own Shares
13th Mar 20245:14 pmPRNTransaction in Own Shares
12th Mar 20245:48 pmPRNNet Asset Value(s)
12th Mar 20244:56 pmPRNTransaction in Own Shares
11th Mar 20244:56 pmPRNTransaction in Own Shares
8th Mar 20245:13 pmPRNTransaction in Own Shares
7th Mar 20245:09 pmPRNTransaction in Own Shares
6th Mar 20245:05 pmPRNTransaction in Own Shares
5th Mar 20245:44 pmPRNNet Asset Value(s)
5th Mar 20245:18 pmPRNTransaction in Own Shares
5th Mar 202411:05 amPRNConversion of Securities
4th Mar 20245:12 pmPRNTransaction in Own Shares
4th Mar 202411:00 amPRNConversion of Securities
1st Mar 20245:45 pmPRNTransaction in Own Shares
1st Mar 202410:37 amPRNTotal Voting Rights
29th Feb 20245:09 pmPRNTransaction in Own Shares
28th Feb 20245:20 pmPRNTransaction in Own Shares
27th Feb 20245:26 pmPRNTransaction in Own Shares
27th Feb 20244:26 pmPRNNet Asset Value(s)
26th Feb 20245:22 pmPRNTransaction in Own Shares
23rd Feb 20245:49 pmPRNTransparency Reporting
23rd Feb 20245:25 pmPRNTransaction in Own Shares
23rd Feb 20245:10 pmPRNNet Asset Value(s)
23rd Feb 20249:50 amPRNMonthly Shareholder Report - January 2024
22nd Feb 20245:16 pmPRNTransaction in Own Shares
21st Feb 20245:28 pmPRNTransaction in Own Shares
20th Feb 20245:08 pmPRNTransaction in Own Shares
20th Feb 20244:12 pmPRNNet Asset Value(s)
19th Feb 20245:10 pmPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.